Masaki Nakao, PhD

Nakao's clinical lens starts with diagnostic detail and individualized planning. Her ophthalmology background shows in the emphasis on small functional changes that affect quality of life, while her regenerative-medicine training supports Tokyo Relife's use of stem cell, exosome, and fibroblast protocols. Expect a physician-led plan built around biomarkers, goals, treatment eligibility, and careful communication.

• Retinal-cell research at Harvard. Nakao spent her post-PhD research period at Massachusetts Eye and Ear Infirmary, Harvard Medical School, working in the biology of retinal injury and regeneration.
• Published cell-biology work. Her confirmed papers under Kayama M cover photoreceptor stress response, TNF-alpha-mediated cell death, and embryonic stem cell-derived corneal epithelial cells.
• Ophthalmology plus anti-aging medicine. She carries Japanese board certification in ophthalmology and anti-aging medicine, giving Tokyo Relife a clinical director with both specialty-care and regenerative-science grounding.

• Confirm the physician assignment. Nakao is listed as Director; for a high-spend regenerative protocol, ask whether she personally handles your consult, procedure planning, infusion review, or follow-up.
• Plan around cell-therapy timing. Stem cell care can require separate visits for consultation, tissue collection, culture, and infusion. Ask for the schedule before booking travel.
• Use the clinic's language support. Nakao's core language is Japanese; the clinic also lists English and Simplified Chinese support for international patients.